RARA CRAFT DATABASE for FDA Medical Devices
510(k)K243181

FDA DEVICE FACTS

Foundation Dermal Regeneration Scaffold Plus (DRS+) Solo

Bionova Medical, Inc.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEOctober 31, 2024PRODUCT CODEFRO

Indications for use

Foundation DRS+ Solo is indicated for the management of wounds including:  Full thickness and partial thickness wounds  Pressure ulcers  Venous ulcers  Ulcers caused by mixed vascular etiologies  Diabetic ulcers  First degree burns  Partial thickness burns (superficial second-degree burns)  Donor sites and other bleeding surface wounds  Abrasions  Trauma wounds (abrasions, lacerations, skin tears)  Dehisced wounds  Surgical wounds (donor sites/grafts, post-Moh’s surgery, post-laser surgery, podiatric, wound dehiscence) Foundation DRS+ Solo may be cut to size.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 16, 2026